추가 설명:
Canertinib dihydrochloride (CAS 289499-45-2) is manufactured directly by Shanghai Rlavie Technology Co.,ltd at a minimum purity of 98%, meeting a wide range of pharmacopoeial standards including ChP, USP, BP, EP, and JP. Certificates of analysis along with HNMR and HPLC/GC data are available on request, samples are provided, and the product is distributed across North and South America, Europe, Australasia, Asia, the Middle East, and Africa.
평가 & 댓글 남기기